Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Forschner

Showing results (81-90 of 157) with videos related to

Pageof 16
Sort By:
Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.
Cancers|June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free SurvivalTimo E Schank, Andrea Forschner, Michael Max Sachse, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CTAntonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2017
Safety of shortened infusion times for combined ipilimumab and nivolumabMaximilian Gassenmaier, Hans-Peter Lipp, Alexander Scheu, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
Genomics of Immunotherapy-Associated Hyperprogressors-LetterAndrea Forschner, Heike Niessner, Yvonne Möller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Maria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 10, 2019
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapyMaria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknessesMaja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Pageof 16

Showing results (81-90 of 157) with videos related to

Sort By:
Pageof 16
Cancers|December 10, 2021
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical ChemistryLina María Serna-Higuita, Teresa Amaral, Andrea Forschner, et al.
Cancers|June 2, 2021
Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free SurvivalTimo E Schank, Andrea Forschner, Michael Max Sachse, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CTAntonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2017
Safety of shortened infusion times for combined ipilimumab and nivolumabMaximilian Gassenmaier, Hans-Peter Lipp, Alexander Scheu, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2021
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
Genomics of Immunotherapy-Associated Hyperprogressors-LetterAndrea Forschner, Heike Niessner, Yvonne Möller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2020
Maria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 10, 2019
Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapyMaria-Ioanna Stefanou, Irina Gepfner-Tuma, Cornelia Brendle, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 14, 2020
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknessesMaja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Pageof 16